PPT- Cancer Monoclonal Antibodies Market Growth, Demand and Challenges of the Key Industry Players

Global Cancer Monoclonal Antibodies Market Research Report and Forecast 20212026

© 2019 IMARC All Rights Reserved

Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group

About IMARC Group

Report Description

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights

Report Description

Global Cancer Monoclonal Antibodies Market Outlook 2026: According to the latest report by IMARC Group, titled " Cancer Monoclonal Antibodies Market: Global Industry Trends, Share, Size, Growth, Opportunity and For ecast 2021-2026" , the global cancer monoclonal antibodies market is currently witnessing strong growth.

Cancer monoclonal antibodies refer to laboratory-produced molecules that are designed to treat cancer. These proteins are engineered to mimic the role of antibodies that are naturally produced by the human body to aid the immune system in fighting cancer cells.

They further bind to the antigens that are present on the surface of cancer cells, trigger the destruction of cell membranes and block cell growth by obstructing the connection with growth-promoting proteins.

As a result, numerous monoclonal antibodies, including murine, chimeric and humanized antibodies, are widely used in the treatment of liver, blood and breast cancer.

Request for a free sample report: https://www.imarcgroup.com/cancer-monoclonal-antibodies-market/requestsample

Report Description and Highlights

Report Description

Global Cancer Monoclonal Antibodies Market Trends: The market is primarily driven by the rising prevalence of cancer on the global level. This has increased the requirement for efficient cancer treatments, owing to which monoclonal antibody therapy is gaining prominence in the healthcare sector.

Its clinical usage is widely associated with improved outcomes as compared to other forms of cancer therapies. Unlike conventional treatments, such as radiotherapy and chemotherapy, monoclonal antibodies target the cancer cells while leaving the healthy cells unaffected, which minimizes the side effects.

The advent of next-generation sequencing (NGS) and target gene selection is acting as another major growth-inducing factor. These technologies have led to the development of cost-effective monoclonal antibodies, which are gaining widespread preference among healthcare professionals.

Extensive research and development (R&D) activities in genomics, coupled with the rising healthcare expenditure and investments by government and private entities, are expected to provide an impetus to the market growth.

Report Description Report Description and Highlights Market Summary: Breakup by Medication Type: • Bevacizumab (Avastin) • Rituximab (Rituxan) • Trastuzumab (Herceptin) • Cetuximab (Erbitux) • Panitumumab (Vectibix) • Others Breakup by Application: • Breast Cancer • Blood Cancer • Liver Cancer • Brain Cancer • Colorectal Cancer • Others

Report Description Report Description and Highlights Breakup by Application: • Breast Cancer • Blood Cancer • Liver Cancer • Brain Cancer • Colorectal Cancer • Others Breakup by End-User: • Hospitals and Clinics • Pharmacies • Research Laboratories • Others Breakup by Antibody Type: • Murine Antibodies • Chimeric Antibodies • Humanized Antibodies • Others

Report Description Report Description and Highlights Breakup by End-User: • Hospitals and Clinics • Pharmacies • Research Laboratories • Others Breakup by Region: • North America • Europe • Asia Pacific • Latin America • Middle East and Africa On account of the aforementioned factors, the market is anticipated to witness strong growth during 2021-2026.

Report Description and Highlights

Report Description

Competitive Landscape With Keyplayer: • AbbVie Inc. • Amgen Inc. • Bristol-Myers Squibb • Eli Lilly and Company • Genmab A/S • GlaxoSmithKline plc • Johnson & Johnson Services Inc. • Merck & Co. Inc. • Novartis AG • Pfizer Inc. • F. Hoffmann-La Roche Ltd • Seattle Genetics Inc. • Spectrum Pharmaceuticals Inc. View Report TOC, Figures and Tables: https://www.imarcgroup.com/cancer-monoclonal-antibodies-market

A partial List of

We are the trusted business partners to the

Clients world's leading corporates, governments, and ourPartial ClientsList of institutions

A partial List of

We are the trusted business partners to the

of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions

Report Description and Highlights

Report Description

© 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com